Breaking News Instant updates and real-time market news.

SGH

Smart Global

$27.19

-1.76 (-6.08%)

, EMKR

Emcore

$4.59

-0.03 (-0.65%)

19:08
10/04/18
10/04
19:08
10/04/18
19:08

Fly Intel: After Hours Movers

UP AFTER EARNINGS: SMART Global Holdings (SGH) up 14.1%. ALSO HIGHER: EMCORE Corp (EMKR) up 9.9% after raised Q4 guidance... Chef's Warehouse (CHEF) up 6.3% after entering S&P SmallCap 600 index... Verastem (VSTM) up 4.0% after publication of Phase 3 DUO results in Blood... Paratek Pharma (PRTK) up 2.8% after announcing EMA acceptance of MAA for omadacycline. DOWN AFTER EARNINGS: LeMaitre Vascular (LMAT) down 15.1%... Costco (COST) down 2.5%. ALSO LOWER: Cutera (CUTR) down 16% after lowering FY18 guidance on Juliet headwinds.

SGH

Smart Global

$27.19

-1.76 (-6.08%)

EMKR

Emcore

$4.59

-0.03 (-0.65%)

CHEF

Chefs' Warehouse

$34.35

-1.32 (-3.70%)

VSTM

Verastem

$6.81

-0.19 (-2.71%)

PRTK

Paratek Pharmaceuticals

$11.32

1.27 (12.64%)

LMAT

LeMaitre

$36.01

-0.61 (-1.67%)

COST

Costco

$231.69

-1.49 (-0.64%)

CUTR

Cutera

$29.79

-0.575 (-1.89%)

  • 04

    Oct

  • 04

    Oct

  • 05

    Oct

  • 09

    Oct

  • 10

    Oct

  • 23

    Oct

  • 06

    Nov

  • 06

    Nov

  • 27

    Nov

SGH Smart Global
$27.19

-1.76 (-6.08%)

08/06/18
STFL
08/06/18
NO CHANGE
STFL
Stifel says Applied, Lam to be beneficiaries of NAND capital intensity step-up
Ahead of this week's upcoming Flash Memory Summit, Patrick Ho shared his view of how he expects capital intensity trends continue to increase as the NAND industry moves to 96 layers and above over the next few years. From a stocks perspective, he believes the biggest beneficiaries of the step-up will remain Applied Materials (AMAT) and Lam Research (LRCX), while also noting that MKS Instruments (MKSI) can benefit from its leadership position in many areas where it supplies both Applied and Lam. Stating that he supports Ho's view on the memory industry's increasing capital intensity, Stifel analyst Kevin Cassidy said in his own note to investors that he expects FMS conference keynotes to discuss the expanding markets for NAND Flash pushing total revenue and profits up despite the industry's increasing capital expenditures driving average selling prices lower. Cassidy also noted the first ever MRAM Developers Day will be held Monday, August 6, stating that he views this as significant for expanding the MRAM eco-system led by Everspin (MRAM). Other NAND Flash names Cassidy has previously been positive about include Micron (MU) and Smart Global (SGH).
06/22/18
STFL
06/22/18
NO CHANGE
Target $61
STFL
Buy
Smart Global price target raised to $61 from $56 at Stifel
Stifel analyst Kevin Cassidy said he believes Smart Global's "bold moves" to expand will accelerate growth while diversifying the company's end markets and noted that management stated along with the company's quarterly report that demand for PC's and smart phones in Brazil remains strong. Following the report Cassidy raised his revenue and EPS estimates for Smart Global and increased his price target on the stock to $61. He maintains a Buy rating on the name.
05/15/18
STFL
05/15/18
NO CHANGE
Target $101
STFL
Buy
NAND flash negativity creates buying opportunity in Micron, says Stifel
Stifel analyst Kevin Cassidy said DRAM prices are tracking above his previous estimates for the May-ending quarter, while the NAND flash market "is growing and far from collapsing, as the bear case has it." The NAND flash negativity is overdone, creating buying opportunities in Micron (MU), Smart Global (SGH) and Western Digital (WDC), according to Cassidy. He raised his price target on Micron shares to $101 from $95 while maintaining a Buy rating on the stock. The firm also has Buy ratings on Smart Global and Western Digital.
04/26/18
STFL
04/26/18
NO CHANGE
STFL
Signs points to continued strong demand for memory, says Stifel
Following the quarterly reports from SK Hynix and Samsung, Stifel analyst Kevin Cassidy said industry data points continue to suggest demand for memory remains strong, primarily from the data center. He also believes memory suppliers continue to act rationally in maintaining incremental supply growth. Cassidy added that his average selling price data in the May quarter to date is tracking ahead of his estimates for both Micron (MU) and SMART Global (SGH).
EMKR Emcore
$4.59

-0.03 (-0.65%)

05/04/18
05/04/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Huntington Ingalls (HII) upgraded to Outperform from Market Perform at Wells Fargo with analyst Sam Pearlstein saying he believes the company's free cash flow will be higher than previously expected in 2019. 2. Valvoline (VVV) upgraded to Neutral from Underweight at JPMorgan with analyst Jeffrey Zekauskas saying he believes the valuation at current levels is fair. 3. Pandora (P) upgraded to Buy from Neutral at B. Riley FBR and to Buy from Hold at SunTrust. 4. Terex (TEX) upgraded to Buy from Hold at Vertical Research with analyst Joseph O'Dea citing improving pricing, valuation, and cycle upside. 5. Emcore (EMKR) upgraded to Buy from Neutral at B. Riley FBR. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/18
NORL
08/03/18
DOWNGRADE
Target $5
NORL
Market Perform
Emcore downgraded to Market Perform from Outperform at Northland
Northland analyst Tim Savageaux downgraded Emcore to Market Perform from Outperform, stating that while the company's Q3 report and outlook points to a long awaited trough and recovery in CATV optics revenue, new issues around manufacturing execution and product transitions have surfaced. The analyst, who noted the company still has a "significant" cash balance and attractive InP fab assets, lowered his price target on Emcore to $5.00 from $6.50.
05/04/18
RILY
05/04/18
UPGRADE
Target $6
RILY
Buy
Emcore upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Dave Kang upgraded Emcore to Buy and raised his price target for the shares to $6.00 from $5.75. The upgrade follows yesterday's Q2 results.
05/04/18
RILY
05/04/18
UPGRADE
RILY
Buy
Emcore upgraded to Buy from Neutral at B. Riley FBR
CHEF Chefs' Warehouse
$34.35

-1.32 (-3.70%)

10/01/18
BMOC
10/01/18
DOWNGRADE
Target $38
BMOC
Market Perform
Chefs' Warehouse downgraded to Market Perform at BMO Capital on valuation
As reported earlier, BMO Capital analyst Kelly Bania downgraded Chef's Warehouse to Market Perform from Outperform but raised her price target to $38 from $34. The analyst cites a more balanced risk-reward on the stock after its recent price advance, saying its current valuation still reflects its "potential to reach a long-term EBITDA margin goal of 7%". Bania also remains positive on Chef's Warehouse continued tailwinds of "high-quality specialty and center of plate products, benefits from investments in technology, management, and infrastructure", margin management tool and more "careful" approached to acquisitions and integration.
10/01/18
BMOC
10/01/18
DOWNGRADE
BMOC
Market Perform
Chefs' Warehouse downgraded to Market Perform from Outperform at BMO Capital
09/26/18
JEFF
09/26/18
DOWNGRADE
Target $39
JEFF
Hold
Chefs' Warehouse downgraded to Hold from Buy at Jefferies
Jefferies analyst Christopher Mandeville downgraded Chefs' Warehouse to Hold while raising his price target for the shares to $39 from $32. The analyst cites valuation for the downgrade as he sees little room for multiple expansion following the recent rally in the stock. However, after meeting with management, Mandeville continues to see a favorable longer term outlook for Chefs' Warehouse.
08/02/18
LOOP
08/02/18
NO CHANGE
Target $31
LOOP
Buy
Chefs' Warehouse remains in accelerated profit growth phase, says Loop Capital
Loop Capital analyst Andrew Wolf kept his Buy rating and nudged his price target on Chefs' Warehouse to $31 from $29 after its Q2 earnings beat and a raise in FY18 guidance. The analyst states that the company remains in the "earlier stage of an accelerated profit growth period " amid strong volume gains and margin expansion as it leverages its infrastructure in the specialty and protein foodservice merchandising.
VSTM Verastem
$6.81

-0.19 (-2.71%)

07/09/18
OPCO
07/09/18
NO CHANGE
Target $16
OPCO
Outperform
Verastem price target raised to $16 from $11 at Oppenheimer
Oppenheimer analyst Leah Rush Cann raised her price target for Verastem to $16 from $11 to account for an increased average forward price-to-sales multiple of the biotechnology sector. The analyst reiterates an Outperform rating on the shares.
07/13/18
BTIG
07/13/18
INITIATION
Target $17
BTIG
Buy
Verastem initiated with a Buy at BTIG
BTIG analyst Robert Hazlett initiated Verastem with a Buy rating and a price target of $17. The analyst cites the potential of the company's pipeline - namely the "late-stage, first-in-class molecule Duvelisib that selectively targets the delta and gamma phosphoinositide 3-kinase isoforms, central signaling pathways in cancer cell proliferation and survival". Hazlett adds that its " successful Phase 3 DUO trial in relapsed/refractory chronic lymphocytic leukemia, combined with solid data from the Phase 2 DYNAMO study in refractory follicular lymphoma, have led to Duvelisib receiving a Priority Review from FDA" with an upcoming Oct 5th PDUFA, as well as a licensing deal. The analyst models potential U.S. peak revenue over $500M and international revenue over $350M in Duvelisib's initial indications.
08/09/18
RAJA
08/09/18
NO CHANGE
RAJA
Verastem price target raised to $12 from $7 at Raymond James
09/25/18
HCWC
09/25/18
NO CHANGE
Target $15
HCWC
Buy
Verastem price target raised to $15 from $10 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Verastem to $15 after the FDA approved the company's lead product, Copiktra , for the treatment of third-line chronic lympocytic leukemia, small lympocytic leukemia, and follicular lymphoma. Not unexpectedly, the FDA has included a boxed warning highlighting the increased risk of serious infections, diarrhea, and colitis with Copiktra, the analyst adds. He expects Copiktra to generate revenues of $178M for these three indications by 2025 and keeps a Buy rating on Verastem.
PRTK Paratek Pharmaceuticals
$11.32

1.27 (12.64%)

08/08/18
RAJA
08/08/18
NO CHANGE
RAJA
Outperform
AdCom vote increases chances of Paratek's omadacycline approval, says Raymond James
Raymond James analyst Laura Chico notes that the FDA's Advisory Committee voted 17-1 in favor of approval for Paratek Pharmaceuticals' omadacycline in skin infections and 14-4 in favor of approval in pneumonia. While the analyst acknowledges that the FDA is not bound by the committee's decision, they nearly always follow the recommendation. Thus, she thinks the vote incrementally increases the chances for an omadacycline approval. Chico reiterates an Outperform rating on the shares.
08/09/18
WEDB
08/09/18
NO CHANGE
Target $20
WEDB
Tone of Paratek advisory committee meeting 'extremely positive,' says Wedbush
Wedbush analyst Robert Driscoll said the tone of yesterday's antimicrobials drug advisory committee meeting was "extremely positive" regarding to the data presented by Paratek and he expects full approval of omadacycline for the treatment of both acute bacterial skin infections and community-acquired bacterial pneumonia in early October. He believes the flexible dosing, low risk of C. difficile and lack of drug-drug interactions will support significant commercial success of omadacycline. Driscoll keeps an Outperform rating and $20 price target on Paratek shares.
08/27/18
BOFA
08/27/18
INITIATION
Target $13
BOFA
Neutral
Paratek Pharmaceuticals initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Jason Gerberry initiated Paratek Pharmaceuticals with a Neutral and $13 price target.
08/06/18
HCWC
08/06/18
NO CHANGE
Target $55
HCWC
Buy
Paratek risk/reward favorable into Wednesday's panel, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce believes the risk/reward for Paratek Pharmaceuticals is "positively-skewed" into Wednesday's FDA panel meeting for omadacycline. The analyst expects a "relatively smooth" panel and would be buyers of the stock heading into the early October FDA action date. Arce keeps a Buy rating on Paratek with a $55 price target.
LMAT LeMaitre
$36.01

-0.61 (-1.67%)

10/02/18
ROTH
10/02/18
DOWNGRADE
Target $39
ROTH
Neutral
LeMaitre downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst David Solomon downgraded LeMaitre to Neutral from Buy, while raising the shares' price target to $39 from $38, citing valuation after assuming coverage of the stock. The analyst notes that the company announced that it acquired Applied Medical's vascular clot management business for $14.2M. Among the key takeaways, the analyst highlights that the acquired products bolster its line of embolectomy catheters, and points out that LeMaitre's appetite for another acquisition remains.
06/25/18
LSCM
06/25/18
INITIATION
Target $45
LSCM
Buy
LeMaitre initiated with a Buy at Lake Street
Lake Street analyst Brooks O'Neil initiated LeMaitre Vascular with a Buy rating and $45 price target, contending that its recent biologics-focused acquisitions give it rapidly growing niche products that its sales organization can cross-sell to its installed base of vascular surgeons to expand its "already successful business."
06/08/18
06/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pfizer (PFE) and Eli Lilly (LLY) were initiated with an Overweight at Cantor Fitzgerald. 2. LivaNova (LIVN) initiated with a Buy at Stifel. 3. Occidental Petroleum (OXY) and Chevron (CVX) were initiated with a Buy at Mizuho while ConocoPhillips (COP) and Exxon Mobil (XOM) were initiated with a Neutral. 4. LeMaitre (LMAT) resumed with a Buy at Roth Capital. 5. Savara (SVRA) initiated with an Outperform, sees 300% upside, says Evercore ISI. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/08/18
ROTH
06/08/18
INITIATION
Target $38
ROTH
Buy
LeMaitre resumed with a Buy at Roth Capital
Roth Capital analyst Scott Henry resumed coverage of LeMaitre Vascular with a Buy rating and $38 price target, as he expects resumed sales-force expansion to drive organic growth in the near-term and thinks the company's Reddick divestiture could help fund an acquisition, which could be a catalyst.
COST Costco
$231.69

-1.49 (-0.64%)

09/28/18
CLVD
09/28/18
NO CHANGE
CLVD
Neutral
Costco sales checks look strong in September, says Cleveland Research
Cleveland Research analyst Scott Bender said his checks suggest sales trends have remained strong for Costco in September after a good August. The analyst, who sees upside to Costco's Q4 EPS versus consensus, maintains a Neutral rating on Costco shares.
09/17/18
09/17/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Visa (V) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst James Schneider citing recent share out-performance. 2. Hormel Foods (HRL) downgraded to Market Perform from Outperform at BMO Capital with analyst Kenneth Zaslow citing valuation. 3. Costco (COST) downgraded to Equal Weight from Overweight at Barclays with analyst Karen Short citing valuation. 4. LyondellBasell (LYB) downgraded to Neutral from Buy at Citi with analyst P.J. Juvekar saying the current rise in ethane is likely to persist until Q2 of 2019. 5. Revance (RVNC) downgraded to Market Perform from Outperform at JMP Securities with analyst Donald Ellis citing Botox study data released by Allergan (AGN). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/17/18
LEHM
09/17/18
DOWNGRADE
Target $240
LEHM
Equal Weight
Costco downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Karen Short downgraded Costco Wholesale (COST) to Equal Weight with an unchanged price target of $240. The analyst cites valuation for the downgrade following the recent rally in the stock. She also downgraded Sprouts Farmers Market (SFM) this morning to Equal Weight for a similar rationale.
10/01/18
BARD
10/01/18
NO CHANGE
Target $250
BARD
Outperform
Costco momentum 'robust' and renewal rates are 'inflecting', says Baird
Baird analyst Peter Benedict kept his Outperform rating and $250 price target on on Costco, saying he sees "good support" for the shares ahead of earnings. The analyst notes that while the higher penetration of lower-margin gas sales and "pragmatic price reinvestment" will weigh on gross margins, operating leverage will serve as an offset. Benedict also sees "robust" sales momentum and inflecting renewal rate preserving the stock's position as a "growth staple".
CUTR Cutera
$29.79

-0.575 (-1.89%)

03/13/18
03/13/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Verizon (VZ), AT&T (T), and T-Mobile (TMUS) were initiated with a Buy at Guggenheim while Sprint (S) was initiated with a Sell. 2. CNO Financial (CNO) initiated with an Outperform at William Blair. 3. GMS Inc. (GMS) initiated with a Buy at Nomura Instinet. 4. Core Laboratories (CLB) assumed with a Neutral at Piper Jaffray. 5. Cutera (CUTR) initiated with an Overweight at Stephens. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/16/18
STFL
04/16/18
INITIATION
Target $55
STFL
Hold
Cutera initiated with a Hold at Stifel
Stifel analyst Jonathan Black initiated Cutera with a Hold and $55 price target.
03/13/18
SPHN
03/13/18
INITIATION
Target $60
SPHN
Overweight
Cutera initiated with an Overweight at Stephens
Stephens analyst Chris Cooley started Cutera with an Overweight rating and $60 price target, as he believes that the company can sustain or even improve on the momentum seen in the early innings of its "total corporate makeover." He also notes Cutera's valuation, which he says is at an approximate 30% to comparable peers in medical technology.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,188.53

-2.26 (-0.19%)

, GOOGL

Alphabet Class A

$1,190.41

0.15 (0.01%)

18:25
08/22/19
08/22
18:25
08/22/19
18:25
Hot Stocks
Google disabled 210 YouTube channels related to ongoing Hong Kong protests »

Google (GOOG) said in a…

GOOG

Alphabet

$1,188.53

-2.26 (-0.19%)

GOOGL

Alphabet Class A

$1,190.41

0.15 (0.01%)

FB

Facebook

$182.08

-1.48 (-0.81%)

TWTR

Twitter

$42.17

-0.63 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

NUAN

Nuance

$17.31

-0.14 (-0.80%)

18:24
08/22/19
08/22
18:24
08/22/19
18:24
Syndicate
Nuance files Form 10 registration statement for planned spin-off of Cerence »

Nuance Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$148.26

0.86 (0.58%)

18:23
08/22/19
08/22
18:23
08/22/19
18:23
Hot Stocks
Salesforce co-CEO: We had a very strong second quarter »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

RVLT

Revolution Lighting

$0.34

-0.0124 (-3.57%)

18:10
08/22/19
08/22
18:10
08/22/19
18:10
Hot Stocks
Revolution Lighting discloses additional delisting determination from Nasdaq »

Revolution Lighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$70.16

-0.38 (-0.54%)

18:05
08/22/19
08/22
18:05
08/22/19
18:05
Hot Stocks
Iberiabank CEO Daryl Byrd sells over $840K in company shares »

Iberiabank CEO Daryl Byrd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

RMNI

Rimini Street

$4.77

-0.11 (-2.25%)

, ORCL

Oracle

$53.18

-0.08 (-0.15%)

18:02
08/22/19
08/22
18:02
08/22/19
18:02
Hot Stocks
San Fang Chemical switches to Rimini Street support for Oracle EBS »

Rimini Street (RMNI)…

RMNI

Rimini Street

$4.77

-0.11 (-2.25%)

ORCL

Oracle

$53.18

-0.08 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$148.26

0.86 (0.58%)

18:01
08/22/19
08/22
18:01
08/22/19
18:01
Hot Stocks
Salesforce says Customer 360 will be huge growth driver over next decade »

Says: Momentum in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

AAC

AAC Holdings

$0.60

-0.0327 (-5.17%)

17:57
08/22/19
08/22
17:57
08/22/19
17:57
Hot Stocks
AAC Holdings discloses NYSE listing notice »

AAC Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

17:32
08/22/19
08/22
17:32
08/22/19
17:32
General news
Fed Balance Sheet Level data reported »

Week of 8/21 Fed Balance…

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:30
08/22/19
08/22
17:30
08/22/19
17:30
Hot Stocks
HP Inc. says notebooks accounted for 39% of revenue in Q3 »

Says supplies category…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

17:28
08/22/19
08/22
17:28
08/22/19
17:28
General news
Money Supply M2 Weekly Change data reported »

Week of 8/12 Money Supply…

TRPX

Therapix Biosciences

$2.35

(0.00%)

17:27
08/22/19
08/22
17:27
08/22/19
17:27
Syndicate
Breaking Syndicate news story on Therapix Biosciences »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$141.38

-0.36 (-0.25%)

17:26
08/22/19
08/22
17:26
08/22/19
17:26
Hot Stocks
SPDR Gold Shares holdings rise to 854.84MT to 851.91MT »

This is the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

17:19
08/22/19
08/22
17:19
08/22/19
17:19
Earnings
VMware sees Q3 adjusted EPS $1.42, consensus $1.57 »

Sees Q3 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

  • 10

    Oct

CRWD

Crowdstrike

$93.04

-3.5 (-3.63%)

, CBLK

Carbon Black

$24.52

1.77 (7.78%)

17:14
08/22/19
08/22
17:14
08/22/19
17:14
Hot Stocks
Crowdstrike lower after Carbon Black acquisition »

Shares of cybersecurity…

CRWD

Crowdstrike

$93.04

-3.5 (-3.63%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:07
08/22/19
08/22
17:07
08/22/19
17:07
Hot Stocks
HP Inc. says CEO Dion Weisler will step down to deal with family health matter »

Says Enrique Lores, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

NP

Neenah Paper

$66.14

-0.455 (-0.68%)

17:05
08/22/19
08/22
17:05
08/22/19
17:05
Hot Stocks
Neenah Paper CFO sells 7.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:04
08/22/19
08/22
17:04
08/22/19
17:04
Hot Stocks
HP Inc. falls over 5% amid slowdown in printer sales »

Shares of HP Inc. are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

NKE

Nike

$83.27

0.46 (0.56%)

17:03
08/22/19
08/22
17:03
08/22/19
17:03
Periodicals
Michael Avenatti plans subpoenas to prove Nike claims, Bloomberg says »

Attorney Michael Avenatti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

17:00
08/22/19
08/22
17:00
08/22/19
17:00
Hot Stocks
HP Inc. printing net revenue was down 5% year over year »

Printing net revenue was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

SYY

Sysco

$73.32

1.06 (1.47%)

16:56
08/22/19
08/22
16:56
08/22/19
16:56
Hot Stocks
Sysco director Koerber sells 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 25

    Sep

  • 01

    Oct

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

, CBLK

Carbon Black

$24.52

1.77 (7.78%)

16:54
08/22/19
08/22
16:54
08/22/19
16:54
Earnings
VMware raises FY20 EPS view to $6.54 from $6.49, consensus $6.52 »

Sees Carbon Black (CBLK)…

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

VMW

VMware

$148.15

0.11 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

AFH

Atlas Financial

$0.41

-0.0323 (-7.29%)

16:53
08/22/19
08/22
16:53
08/22/19
16:53
Hot Stocks
Atlas Financial gives update on ongoing strategic review »

Atlas Financial Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEN

Zendesk

$80.87

0.57 (0.71%)

16:51
08/22/19
08/22
16:51
08/22/19
16:51
Hot Stocks
Zendesk CEO sells 100K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 09

    Sep

  • 10

    Sep

  • 10

    Sep

  • 13

    Nov

CBLK

Carbon Black

$24.52

1.77 (7.78%)

16:50
08/22/19
08/22
16:50
08/22/19
16:50
Hot Stocks
Breaking Hot Stocks news story on Carbon Black »

Carbon Black trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.